Advancing Health Through Clinically Proven Safety

We are dedicated to developing fully natural, and safe products, validated by rigorous scientific research

How the science work

Soybean (Glycine max)

Is a primary plant- based protein source in East Asian countries.

However, fermented soybean offers more health benefits than its unfermented counterpart.

Clinical study 1: GERD

Effect of Fermented Soybean (FSB) Supplementation on Gastroesophageal Reflux Disease (GERD)

Nattome products are clinically proven to relieve heartburn and acid reflux, supported by a research collaboration with UCSI University to ensure scientific credibility and proven effectiveness.

Learn More

KEY INSIGHTS

READ FULL REPORT

GERD SYMPTOMS

  • Heartburn symptoms reduced by 47.6%
  • Regurgitation symptoms reduced by 62.9%
  • Dyspepsia symptoms reduced by 40.9%

INFLAMMATION LEVELS

  • IL-4 reduced by 27.1%
  • IL-6 reduced by 43.5%
  • IL-8 reduced by 19.8%

QUALITY OF LIFE (QOLRAD)

Overall score improved by 13.3%

  • Vitality ↑ 16.7%
  • Eat/drink problems ↑ 15.1%
  • Emotional distress ↑ 13.3%
  • Sleep disturbance ↑ 12.3%
  • Physical/social functioning ↑ 10.8%
READ FULL REPORT

Study Design

STUDY DESIGN - GERD

HEARTBURN (RDQ)

What is this test about?
Reflux Disease Questionnaire (RDQ) – Heartburn symptoms were evaluated.

47.6%

Improvement
Heartburn scores decreased from 0.42 to 0.22 (p<0.01).

Subjects with higher BMI showed better responses to supplementation.

HEARTBURN (RDQ)

STUDY DESIGN - GERD

REGURGITATION (RDQ)

What is this test about?
RDQ – Regurgitation symptoms were measured to assess reflux severity.

62.9%

Improvement
Regurgitation scores decreased from 0.905 to 0.335 (p<0.001).

Older participants showed stronger improvements.

REGURGITATION (RDQ)

STUDY DESIGN - GERD

INFLAMMATION (IL-4, IL-6, IL-8)

What is this test about?
Levels of pro-inflammatory cytokines (IL-4, IL-6, IL-8) associated with GERD severity were tested.

IL-4 ↓27.1% (129.97 → 94.80 pg/mL, p<0.01)
IL-6 ↓43.5% (4.41 → 2.49 pg/mL, p<0.05)

IL-8 ↓19.8% (231.81 → 185.82 pg/mL, p<0.05)

Fermented soybean peptides demonstrated anti-inflammatory effects.

INFLAMMATION (IL-4, IL-6, IL-8)

STUDY DESIGN - GERD

QUALITY OF LIFE (QOLRAD)

What is this test about?
Quality of life was assessed using the QOLRAD questionnaire across 5 domains.

13.3%

Improvement
Overall QOLRAD scores improved from 5.27 to 5.97 (p<0.05).


  • Vitality +16.7%
  • Eat/Drink +15.1%
  • Emotional Distress +13.3%
  • Sleep Disturbance +12.3%
  • Physical/Social +10.8%

96% of participants reported self-perceived improvement in GERD symptoms.

QUALITY OF LIFE (QOLRAD)

Benefit

soybeans fermented with Lactobacillus

  • Previous study demonstrated that soybeans fermented with Lactobacillusdelbrueckii may be able to suppress heartburn in individuals who experience mild tomoderate symptoms
  • A study from Japan has reported that fermented soybean (FSB) such as miso andnatto etc have an essential impact in increasing the function of the immune systemby maintaining the well-balanced gut microbiota. These foods have beneficialcompounds like antioxidants, vitamins, minerals, folic acid, high protein, and probioticbacteria which boost the immune system to fight against infections (4-6).

Clinical study 2: Immunity

Immunomodulatory Potential of Fermented Soy Bean Supplementation: Effects on Immune Fitness

This randomized controlled trial, conducted in 2024, evaluated the efficacy of Nattome supplementation on immunity, antioxidant status, and oxidative stress in 110 participants over a 12-week period.

Learn More

KEY INSIGHTS

READ FULL REPORT

IMMUNITY

  • sIgA levels increased by 31.7%
  • MPO activities reduced by 39.7%

ANTIOXIDANT
STATUS

The Total Antioxidant Capacity (TAC) of
the subjects was increased by 45.6%

OXIDATIVE
STRESS

The malondialdehyde (MDA) levels of the
subjects was reduced by 21.1%

READ FULL REPORT

Study Design

STUDY DESIGN - Immunity

Secretory Immunoglobulin A (sIgA)

What is this test about?
The immunity levels of the subjects were evaluated using the following parameters:
Secretory Immunoglobulin A (sIgA) levels Myeloperoxidase (MPO) activities

31.7%
Improvement
sIgA levels increased from 5.77 ng/mL to 7.60 ng/mL,

Secretory Immunoglobulin A (sIgA)

STUDY DESIGN - Immunity

MYELOPEROXIDASE (MPO) ACTIVITIES

What is this test about?
MPO, an enzyme found in neutrophils, is often used as a biomarker for gut inflammation. Its levels can indicate the severity of inflammatory bowel disease (IBD) and are useful for assessing treatment efficacy.

39.7%

Reduction

MPO activities reduced from 860.74 U/L to 518.83 U/L, representing a 39.7% reduction (P<0.05).

MYELOPEROXIDASE (MPO) ACTIVITIES

STUDY DESIGN - Antioxidant

TOTAL ANTIOXIDANT CAPACITY (TAC)

What is this test about?
TAC measures the antioxidant status of the body. Antioxidants are crucial in modulating gut microbiota and improving disorders such as liver damage, hypertension, diabetes, obesity, and irritable bowel disease (IBD).

45.6%

Improvement
TAC increased from 14.92 U/mL to 21.73 U/mL, reflecting a 45.6% improvement (P<0.01).

TOTAL ANTIOXIDANT CAPACITY (TAC)

STUDY DESIGN - Oxidative Stress

MALONDIALDEHYDE (MDA)

What is this test about?
MDA is a biomarker of oxidative stress. Elevated MDA levels have been associated with the progression and severity of IBD, IBS, and colorectal cancer.

21.1%

Reduction
MDA levels decreased from 42.14 ng/mL to 33.25 ng/mL, representing a 21.1% reduction.

(Note: The difference between groups was not statistically significant.)

MALONDIALDEHYDE (MDA)
OUR SCIENCE-BACKED POSTBIOTIC OUR SCIENCE-BACKED POSTBIOTIC

OUR SCIENCE-BACKED
POSTBIOTIC

POWERED BY
CLINICAL STUDIES

We empower you to achieve optimal gut health, backed by research and innovation. Read our clinical studies and scientific reports.

READ CLINICAL STUDIES